The MIMESIS team is proud to be part of MEDITWIN, an ambitious national consortium bringing together French excellence in science, technology, and medicine to develop virtual twins for medical practice.
Announced on December 11, 2023, in the presence of French President Emmanuel Macron, and supported by the France 2030 investment plan, MEDITWIN unites 14 founding members: Dassault Systèmes as industrial leader, seven University Hospital Institutes (IHUs), Nantes University Hospital, four innovative startups, and Inria through 11 project teams — including MIMESIS.
What is MEDITWIN?
MEDITWIN aims to develop personalized virtual twins of organs, metabolism, and cancer for better diagnosis and treatment. By enabling clinicians to simulate future scenarios for individual patients, the project will deliver seven “virtual healthcare products” across neurology, cardiology, and oncology, deployed on a sovereign industrial cloud platform.
MIMESIS and IHU Strasbourg: tackling metastatic colorectal cancer
Within MEDITWIN, MIMESIS contributes its expertise in real-time computational models and computer-assisted interventions in close collaboration with IHU Strasbourg. As Prof. Didier Mutter, CEO of IHU Strasbourg, highlighted: the project will serve as a powerful catalyst for improving the minimally invasive management of metastatic colorectal cancer, building on the longstanding partnership between IHU Strasbourg, Inria, and the University Hospitals of Strasbourg.
This work aligns directly with MIMESIS’s core research on digital twins for hepatic surgery, combining real-time simulation, medical imaging, and machine learning to assist surgeons during complex interventions.
A five-year initiative
MEDITWIN will run from 2024 to 2029, with financial support from the French government. The project builds on years of pioneering work in virtual twins for healthcare — including Dassault Systèmes’ Living Heart and Living Brain initiatives, and the PEPR digital health program co-directed by Inria and INSERM.
By industrializing, clinically validating, and standardizing these innovations, MEDITWIN will set a new benchmark for quality in healthcare and make the best standards of care accessible worldwide.
Learn more: MEDITWIN project page
This project is funded as part of the France 2030 plan.
